An Orlando biomedical company that attracted more than $16 million in venture-capital investments is embroiled in litigation with a competitor over allegations of false claims advertising and theft of trade secrets.
The company, Vestagen, is fighting a lawsuit from a California competitor, Strategic Partners Inc., and has filed its own lawsuit alleging that SPI hired away one of its top sales executives, who then disclosed some of Vestagen’s secrets. Read more here.
